IP Verse

Fixed Drug Ratios For Treatment Of Hematopoietic Cancers And Proliferative Disorders

Patent No. EP3300601 (titled "Fixed Drug Ratios For Treatment Of Hematopoietic Cancers And Proliferative Disorders") was filed by Celator Pharmaceuticals on Feb 15, 2008. The application was issued on Jan 12, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GENERICS UKOct 12, 2022ELKINGTON AND FIFE
SANDOZOct 11, 2022KRAUS & LEDERER PARTGMBB
STADA ARZNEIMITTELOct 11, 2022HAMM & WITTKOPP

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3300601

CELATOR PHARMACEUTICALS
Application Number
EP17200498A
Filing Date
Feb 15, 2008
Status
Granted And Under Opposition
Dec 10, 2021
Publication Date
Jan 12, 2022
External Links
Slate, Register , Google Patents